• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人骨形态发生蛋白 2(rhBMP-2)在后外侧腰椎融合术中的应用:老年人的并发症。

Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly.

机构信息

Grand Rapids Medical Education Partners, 1000 Monroe Ave NW, Grand Rapids, MI 49503, USA.

出版信息

J Orthop Surg Res. 2013 Jan 14;8:1. doi: 10.1186/1749-799X-8-1.

DOI:10.1186/1749-799X-8-1
PMID:23317417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3621610/
Abstract

STUDY DESIGN

Retrospective cohort study of 1430 patients undergoing lumbar spinal fusion from 2002 - 2009.

OBJECTIVE

The goal of this study was to compare and evaluate the number of complications requiring reoperation in elderly versus younger patients.

SUMMARY OF BACKGROUND DATA

rhBMP-2 has been utilized off label for instrumented lumbar posterolateral fusions for many years. Many series have demonstrated predictable healing rates and reoperations. Varying complication rates in elderly patients have been reported.

MATERIALS AND METHODS

All patients undergoing instrumented lumbar posterolateral fusion of ≤ 3 levels consenting to utilization of rhBMP-2 were retrospectively evaluated. Patient demographics, body mass index, comorbidities, number of levels, associated interbody fusion, and types of bone void filler were analyzed. The age of patients were divided into less than 65 and greater than or equal to 65 years. Complications related to the performed procedure were recorded.

RESULTS

After exclusions, 482 consecutive patients were evaluated with 42.1% males and 57.9% females. Average age was 62 years with 250 (51.9%) < 65 and 232 (48.1%) ≥ 65 years. Patients ≥ 65 years of age stayed longer (5.0 days) in the hospital than younger patients (4.5 days) (p=0.005).Complications requiring reoperation were: acute seroma formation requiring decompression 15/482, 3.1%, bone overgrowth 4/482, 0.8%, infection requiring debridement 11/482, 2.3%, and revision fusion for symptomatic nonunion 18/482, 3.7%. No significant differences in complications were diagnosed between the two age groups. Statistical differences were noted between the age groups for medical comorbidities and surgical procedures. Patients older than 65 years underwent longer fusions (2.1 versus 1.7 levels, p=0.001).

DISCUSSION

Despite being older and having more comorbidities, elderly patients have similar complication and reoperation rates compared to younger healthier patients undergoing instrumented lumbar decompression fusions with rhBMP-2.

摘要

研究设计

回顾性队列研究,纳入 2002 年至 2009 年间接受腰椎融合术的 1430 例患者。

目的

本研究旨在比较和评估老年患者与年轻患者中需要再次手术治疗的并发症数量。

背景资料总结

rhBMP-2 多年来已被超适应证用于器械辅助的腰椎后路融合术。多项研究均显示出可预测的愈合率和再手术率。但也有报道称老年患者的并发症发生率存在差异。

材料和方法

回顾性评估所有接受≤3 个节段的器械辅助腰椎后路融合术并同意使用 rhBMP-2 的患者。分析患者的人口统计学资料、体重指数、合并症、节段数、联合前路融合术及骨填充物类型。将患者年龄分为<65 岁和≥65 岁。记录与手术相关的并发症。

结果

排除后,482 例连续患者接受评估,其中男性占 42.1%,女性占 57.9%。平均年龄为 62 岁,其中 250 例(51.9%)<65 岁,232 例(48.1%)≥65 岁。年龄≥65 岁的患者住院时间更长(5.0 天),而年龄较轻的患者(4.5 天)(p=0.005)。需要再次手术治疗的并发症包括:15/482(3.1%)急性血清肿形成需要减压,4/482(0.8%)骨过度生长,11/482(2.3%)感染需要清创,18/482(3.7%)症状性非融合需要翻修融合术。两组患者的并发症无显著差异。两组患者在合并症和手术方式方面存在统计学差异。年龄>65 岁的患者融合节段更长(2.1 与 1.7 个节段,p=0.001)。

讨论

尽管年龄较大且合并症较多,但接受 rhBMP-2 辅助器械下腰椎减压融合术的老年患者与较年轻、健康的患者相比,其并发症和再手术率相似。

相似文献

1
Recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in posterolateral lumbar spine fusion: complications in the elderly.重组人骨形态发生蛋白 2(rhBMP-2)在后外侧腰椎融合术中的应用:老年人的并发症。
J Orthop Surg Res. 2013 Jan 14;8:1. doi: 10.1186/1749-799X-8-1.
2
Complications of rhBMP-2 utilization for posterolateral lumbar fusions requiring reoperation: a single practice, retrospective case series report.rhBMP-2 用于后路腰椎融合术再手术的并发症:一项单一实践回顾性病例系列报告。
Spine J. 2013 Oct;13(10):1244-52. doi: 10.1016/j.spinee.2013.06.022. Epub 2013 Aug 22.
3
Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.使用 rhBMP-2 进行微创经椎间孔腰椎体间融合术后的临床后遗症。
Spine J. 2013 Sep;13(9):1118-25. doi: 10.1016/j.spinee.2013.07.028.
4
Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.比较接受 rhBMP-2 与自体移植物的患者行经椎间孔腰椎体间融合术的效果。
Spine J. 2018 Mar;18(3):439-446. doi: 10.1016/j.spinee.2017.08.230. Epub 2017 Aug 18.
5
Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 2: BMP dosage-related complications and long-term outcomes in 509 patients.经椎间孔腰椎体间融合术联合 rhBMP-2 治疗脊柱畸形、脊椎滑脱和退行性疾病-第 2 部分:509 例患者中与 BMP 剂量相关的并发症和长期结果。
Spine (Phila Pa 1976). 2013 Jun 1;38(13):1137-45. doi: 10.1097/BRS.0b013e3182880298.
6
Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.后路脊柱融合术中与硬脊膜撕裂相关的重组人骨形态发生蛋白-2 相关并发症。
Spine J. 2011 Jun;11(6):522-6. doi: 10.1016/j.spinee.2010.05.016. Epub 2010 Jul 2.
7
Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.后路腰椎体间融合术联合和不联合骨形成蛋白-2 强化治疗对神经损伤及恢复的影响:一项队列对照研究。
Spine J. 2014 Feb 1;14(2):217-24. doi: 10.1016/j.spinee.2013.06.109. Epub 2013 Nov 20.
8
Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.重组人骨形态发生蛋白-2 与局部骨移植在原发性腰椎椎间融合术中的有效性和安全性。
Spine (Phila Pa 1976). 2014 Jan 15;39(2):164-71. doi: 10.1097/BRS.0000000000000089.
9
Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.经椎间孔腰椎体间融合术联合 rhBMP-2 治疗脊柱畸形、滑脱和退行性疾病--第 1 部分:2 年至 9 年随访的大系列与诊断相关的结局和并发症。
Spine (Phila Pa 1976). 2013 Jun 1;38(13):1128-36. doi: 10.1097/BRS.0b013e31828864e6.
10
RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.经椎间孔腰椎椎间融合术患者中重组人骨形态发生蛋白-2诱导的神经根炎:与剂量的关系
Spine J. 2016 Oct;16(10):1208-1213. doi: 10.1016/j.spinee.2016.06.007. Epub 2016 Jun 22.

引用本文的文献

1
A novel anatomical locked medial femoral condyle plate: a biomechanical study.新型解剖锁定股骨内侧髁接骨板:一项生物力学研究。
Eur J Orthop Surg Traumatol. 2024 Jul;34(5):2767-2772. doi: 10.1007/s00590-024-03993-9. Epub 2024 May 20.
2
Comparative Efficacy of Commonly Available Human Bone Graft Substitutes as Tested for Posterolateral Fusion in an Athymic Rat Model.在无胸腺大鼠模型中对常用人工骨移植替代物进行后外侧融合测试的比较疗效
Int J Spine Surg. 2019 Oct 31;13(5):437-458. doi: 10.14444/6059. eCollection 2019 Oct.
3
Trends Analysis of rhBMP2 Utilization in Single-Level Anterior Lumbar Interbody Fusion in the United States.美国单节段腰椎前路椎间融合术中重组人骨形态发生蛋白2(rhBMP2)应用的趋势分析
Global Spine J. 2018 Apr;8(2):137-141. doi: 10.1177/2192568217701119. Epub 2017 May 16.
4
Trends Analysis of rhBMP Utilization in Single-Level Posterior Lumbar Interbody Fusion in the United States.美国单节段腰椎后路椎间融合术中重组人骨形态发生蛋白(rhBMP)应用的趋势分析
Global Spine J. 2017 Oct;7(7):624-628. doi: 10.1177/2192568217699387. Epub 2017 Jun 30.
5
KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.KDM5A在骨质疏松症期间控制骨形态发生蛋白2诱导的骨髓间充质干细胞成骨分化。
Cell Death Dis. 2016 Aug 11;7(8):e2335. doi: 10.1038/cddis.2016.238.
6
Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States.美国单节段腰椎后路融合术(PLF)中重组人骨形态发生蛋白(rhBMP)应用的趋势分析。
Eur Spine J. 2016 Mar;25(3):783-8. doi: 10.1007/s00586-015-4032-9. Epub 2015 May 24.
7
A consensus statement regarding the utilization of BMP in spine surgery.关于在脊柱手术中使用 BMP 的共识声明。
Curr Rev Musculoskelet Med. 2014 Sep;7(3):208-19. doi: 10.1007/s12178-014-9224-0.
8
Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation.对抗肿瘤坏死因子-α/白细胞介素-1β和骨形态发生蛋白-2激活的丝裂原活化蛋白激酶信号通路在Runx2上汇聚,以调节骨形态发生蛋白-2诱导的成骨细胞分化。
Cell Death Dis. 2014 Apr 17;5(4):e1187. doi: 10.1038/cddis.2014.101.

本文引用的文献

1
Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges.骨形态发生蛋白在老年腰椎管狭窄症脊柱融合手术中的应用:趋势、并发症、再次手术和费用。
Spine (Phila Pa 1976). 2012 Feb 1;37(3):222-30. doi: 10.1097/BRS.0b013e31821bfa3a.
2
Off-label use of bone morphogenetic proteins in the United States using administrative data.美国基于行政数据评估骨形态发生蛋白的标签外使用。
Spine (Phila Pa 1976). 2010 Sep 1;35(19):1794-800. doi: 10.1097/BRS.0b013e3181ecf6e4.
3
Complications and concerns with osteobiologics for spine fusion in clinical practice.临床实践中脊柱融合使用骨生物材料的并发症和关注点。
Spine (Phila Pa 1976). 2010 Aug 1;35(17):1621-8. doi: 10.1097/BRS.0b013e3181ce11cc.
4
Morbidity and mortality in the surgical treatment of 10,329 adults with degenerative lumbar stenosis.10329 例成人退行性腰椎管狭窄症手术治疗的发病率和死亡率。
J Neurosurg Spine. 2010 May;12(5):443-6. doi: 10.3171/2009.11.SPINE09531.
5
Effects of age on perioperative complications of extensive multilevel thoracolumbar spinal fusion surgery.年龄对广泛多节段胸腰椎融合手术围手术期并发症的影响。
J Neurosurg Spine. 2010 Apr;12(4):402-8. doi: 10.3171/2009.10.SPINE08741.
6
The efficacy of rhBMP-2 versus autograft for posterolateral lumbar spine fusion in elderly patients.rhBMP-2 与自体骨在老年患者后路腰椎融合术中的疗效比较。
Eur Spine J. 2010 Jun;19(6):924-30. doi: 10.1007/s00586-009-1248-6. Epub 2009 Dec 30.
7
Osteoinductive bone graft substitutes for lumbar fusion: a systematic review.用于腰椎融合术的诱导成骨骨替代物:系统评价。
J Neurosurg Spine. 2009 Dec;11(6):729-40. doi: 10.3171/2009.6.SPINE08669.
8
National complication rates and disposition after posterior lumbar fusion for acquired spondylolisthesis.获得性腰椎滑脱后路融合术后的国家并发症发生率和处理方式。
Spine (Phila Pa 1976). 2009 Aug 15;34(18):1963-9. doi: 10.1097/BRS.0b013e3181ae2243.
9
Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures.脊柱融合手术中使用骨形态发生蛋白的患病率、并发症及住院费用。
JAMA. 2009 Jul 1;302(1):58-66. doi: 10.1001/jama.2009.956.
10
RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility study.重组人骨形态发生蛋白-2与髂嵴骨移植用于60岁以上患者腰椎融合术的成本效用研究
Spine (Phila Pa 1976). 2009 Feb 1;34(3):238-43. doi: 10.1097/BRS.0b013e31818ffabe.